SPARK THERAPEUTICS, INC. — Lobbying Disclosure | Poliscope

SPARK THERAPEUTICS, INC.

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Spend

$6.5M

Filings

116

Firms Hired

Active Period

2015–2025

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2025	$290,000	6	3
2024	$810,000	12	3
2023	$810,000	12	3
2022	$910,000	12	3
2021	$920,000	12	3
2020	$680,000	12	3
2019	$760,000	12	3
2018	$980,000	14	3
2017	$320,000	13	4
2016	—	7	2
2015	—	4	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
SPARK THERAPEUTICS, INC.	$6,480,000	34
BROWNSTEIN HYATT FARBER SCHRECK, LLP	—	33
JEFFREY J. KIMBELL & ASSOCIATES, INC.	—	43
MONUMENT ADVOCACY	—	6

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	100
SENATE	99
Health & Human Services, Dept of (HHS)	12
Office of Management & Budget (OMB)	10
Centers For Medicare and Medicaid Services (CMS)	8
Office of the Vice President of the United States	2
Executive Office of the President (EOP)	1
Food & Drug Administration (FDA)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	102
Medicare/Medicaid	Medicare/Medicaid	55
Pharmacy	Pharmacy	9
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	6
Insurance	Insurance	2
Copyright/Patent/Trademark	Copyright/Patent/Trademark	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · second_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1 - One Big Beautiful Bill Act; provisions related to health. H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025; provisions related to health. S. 1637 - MVP Act; all provisions.

Client expense: $100,000 · Firm income: —

Matched citations: H.R. 1

H.R. 1262119th Congress

Mikaela Naylon Give Kids a Chance Act

2025 · second_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1262/S. 932 - Give Kids a Chance Act of 2025; all provisions. H.R. 1509/S. 752 - Accelerating Kids Access to Care Act of 2025; all provisions.

Client expense: $100,000 · Firm income: —

Matched citations: H.R. 1262

H.R. 1509119th Congress

Accelerating Kids’ Access to Care Act of 2025

2025 · second_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1262/S. 932 - Give Kids a Chance Act of 2025; all provisions. H.R. 1509/S. 752 - Accelerating Kids Access to Care Act of 2025; all provisions.

Client expense: $100,000 · Firm income: —

Matched citations: H.R. 1509

H.R. 1968119th Congress

Full-Year Continuing Appropriations and Extensions Act, 2025

2025 · second_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1 - One Big Beautiful Bill Act; provisions related to health. H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025; provisions related to health. S. 1637 - MVP Act; all provisions.

Client expense: $100,000 · Firm income: —

Matched citations: H.R. 1968

Show 21 more cited filings

S. 1637119th Congress

MVP Act

2025 · second_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1 - One Big Beautiful Bill Act; provisions related to health. H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025; provisions related to health. S. 1637 - MVP Act; all provisions.

Client expense: $100,000 · Firm income: —

Matched citations: S. 1637

S. 752119th Congress

Accelerating Kids’ Access to Care Act

2025 · second_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1262/S. 932 - Give Kids a Chance Act of 2025; all provisions. H.R. 1509/S. 752 - Accelerating Kids Access to Care Act of 2025; all provisions.

Client expense: $100,000 · Firm income: —

Matched citations: S. 752

S. 932119th Congress

Give Kids a Chance Act of 2025

2025 · second_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1262/S. 932 - Give Kids a Chance Act of 2025; all provisions. H.R. 1509/S. 752 - Accelerating Kids Access to Care Act of 2025; all provisions.

Client expense: $100,000 · Firm income: —

Matched citations: S. 932

H.R. 1262119th Congress

Mikaela Naylon Give Kids a Chance Act

2025 · first_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1509/S. 752 - Accelerating Kids Access to Care Act of 2025, all provisions. H.R. 1262/S. 932 - Give Kids a Chance Act of 2025, all provisions.

Client expense: $190,000 · Firm income: —

Matched citations: H.R. 1262

H.R. 1509119th Congress

Accelerating Kids’ Access to Care Act of 2025

2025 · first_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1509/S. 752 - Accelerating Kids Access to Care Act of 2025, all provisions. H.R. 1262/S. 932 - Give Kids a Chance Act of 2025, all provisions.

Client expense: $190,000 · Firm income: —

Matched citations: H.R. 1509

H.R. 1968119th Congress

Full-Year Continuing Appropriations and Extensions Act, 2025

2025 · first_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2666/S. 4204 - MVP Act, all provisions. H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025, provisions related to health.

Client expense: $190,000 · Firm income: —

Matched citations: H.R. 1968

H.R. 2666119th Congress

CBO Scoring Accountability Act

2025 · first_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2666/S. 4204 - MVP Act, all provisions. H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025, provisions related to health.

Client expense: $190,000 · Firm income: —

Matched citations: H.R. 2666

S. 4204118th Congress

MVP Act

2025 · first_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2666/S. 4204 - MVP Act, all provisions. H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025, provisions related to health.

Client expense: $190,000 · Firm income: —

Matched citations: S. 4204

S. 752119th Congress

Accelerating Kids’ Access to Care Act

2025 · first_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1509/S. 752 - Accelerating Kids Access to Care Act of 2025, all provisions. H.R. 1262/S. 932 - Give Kids a Chance Act of 2025, all provisions.

Client expense: $190,000 · Firm income: —

Matched citations: S. 752

S. 932119th Congress

Give Kids a Chance Act of 2025

2025 · first_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1509/S. 752 - Accelerating Kids Access to Care Act of 2025, all provisions. H.R. 1262/S. 932 - Give Kids a Chance Act of 2025, all provisions.

Client expense: $190,000 · Firm income: —

Matched citations: S. 932

H.R. 2666119th Congress

CBO Scoring Accountability Act

2025 · first_quarter · Firm: JEFFREY J. KIMBELL & ASSOCIATES, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Value-based pricing arrangements; MVP Act - HR 2666

Client expense: — · Firm income: $30,000

Matched citations: HR 2666

H.R. 10445118th Congress

Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025

2024 · fourth_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2666/S. 4204 - MVP Act, all provisions. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025, issues related to PRV and the Accelerating Kids Access to Care Act. Issues related to the CMMI demonstration on Gene and Cell Therapy.

Client expense: $250,000 · Firm income: —

Matched citations: H.R. 10445

H.R. 2666118th Congress

Medicaid VBPs for Patients Act

2024 · fourth_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2666/S. 4204 - MVP Act, all provisions. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025, issues related to PRV and the Accelerating Kids Access to Care Act. Issues related to the CMMI demonstration on Gene and Cell Therapy.

Client expense: $250,000 · Firm income: —

Matched citations: H.R. 2666

H.R. 3433118th Congress

Give Kids a Chance Act of 2024

2024 · fourth_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to gene therapy and rare diseases. H.R. 4758 - Accelerating Kids Access to Care Act, all provisions. H.R. 3433 - Give Kids a Chance Act of 2024, all provisions.

Client expense: $250,000 · Firm income: —

Matched citations: H.R. 3433

H.R. 4758118th Congress

Accelerating Kids’ Access to Care Act

2024 · fourth_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to gene therapy and rare diseases. H.R. 4758 - Accelerating Kids Access to Care Act, all provisions. H.R. 3433 - Give Kids a Chance Act of 2024, all provisions.

Client expense: $250,000 · Firm income: —

Matched citations: H.R. 4758

S. 4204118th Congress

MVP Act

2024 · fourth_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2666/S. 4204 - MVP Act, all provisions. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025, issues related to PRV and the Accelerating Kids Access to Care Act. Issues related to the CMMI demonstration on Gene and Cell Therapy.

Client expense: $250,000 · Firm income: —

Matched citations: S. 4204

H.R. 2666118th Congress

Medicaid VBPs for Patients Act

2024 · fourth_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the development of gene therapies for rare diseases S. 4204/ H.R. 2666 MVP ACT

Client expense: — · Firm income: $60,000

Matched citations: H.R. 2666

S. 4204118th Congress

MVP Act

2024 · fourth_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the development of gene therapies for rare diseases S. 4204/ H.R. 2666 MVP ACT

Client expense: — · Firm income: $60,000

Matched citations: S. 4204

H.R. 2666118th Congress

Medicaid VBPs for Patients Act

2024 · fourth_quarter · Firm: JEFFREY J. KIMBELL & ASSOCIATES, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Value-based pricing arrangements; MVP Act - HR 2666

Client expense: — · Firm income: $30,000

Matched citations: HR 2666

H.R. 2666118th Congress

Medicaid VBPs for Patients Act

2024 · third_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2666/S. 4204 - MVP Act, all provisions. Issues related to the CMMI demonstration on Gene and Cell Therapy.

Client expense: $180,000 · Firm income: —

Matched citations: H.R. 2666

H.R. 3433118th Congress

Give Kids a Chance Act of 2024

2024 · third_quarter · Firm: SPARK THERAPEUTICS, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to gene therapy and rare diseases. H.R. 4758 - Accelerating Kids Access to Care Act, all provisions. H.R. 3433 - Give Kids a Chance Act of 2024, all provisions.

Client expense: $180,000 · Firm income: —

Matched citations: H.R. 3433

Source: Senate LDA